| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6099946 | Journal of Crohn's and Colitis | 2013 | 4 Pages |
Abstract
Adalimumab shows some efficacy as a maintenance strategy in Ulcerative Colitis, but only a limited proportion of patients remain well on continued treatment at 2Â years.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Edel McDermott, Seamus Murphy, Denise Keegan, Diarmuid O'Donoghue, Hugh Mulcahy, Glen Doherty,